BC
WVE icon

Bayforest Capital’s Wave Life Sciences WVE Stock Holding History

Bayforest Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$284K Buy
+48,854
New +$324K 0.26% 78

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Bayforest Capital's WVE Position: Q2 2026 in Review

Bayforest Capital opened a new position in Wave Life Sciences (WVE) in Q2 2026: 48,854 shares worth $284K. The stake represents 0.26% of the portfolio and ranks #78 among its holdings.

239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Bayforest Capital held 48,854 shares of Wave Life Sciences worth $284K as of Q2 2026.
  • Wave Life Sciences was a new Bayforest Capital position in Q2 2026.
  • Wave Life Sciences made up 0.26% of Bayforest Capital's portfolio in Q2 2026, its #78 holding.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.